A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects

NCT04778072 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Premenopause
Iron-deficiency
Iron Adverse Reaction
Iron Deficiency Anemia
Heavy Menstrual Bleeding

Interventions

DIETARY_SUPPLEMENT: Ferrous sulfate 14mg once daily
DIETARY_SUPPLEMENT: Ferrous sulfate 25mg once daily
DIETARY_SUPPLEMENT: Ferrous sulfate 25mg twice daily

Sponsor

Solvotrin Innovations Ltd